BiocurePharm Corporation announced a non-brokered private placement of 12,500 shares at issue price of CAD 4.328 per share for gross proceeds of CAD 54,100 on January 16, 2023. The transaction included participation from returning investor Biocure Technology Inc. and it holds a 93.42-per-cent interest in the company.